Resurfacing HSBC's April call: Lenskart started at Hold even as it sees room for 7,000 India stores

HSBC's April note initiating coverage with a Rs 513 target, implying about 2% upside, resurfaces now—citing Lenskart's strong store economics and omnichannel model to support expansion from roughly 2,500 stores, but noting valuation limits near-term upside.

— FiledTue, 21 Jul, 2026, 09:50 IST·First seen Tue, 21 Jul, 2026, 09:50 IST·Source Financial Express · BrandWagon

What happened

HSBC initiated Lenskart at Hold with a Rs 513 target, citing valuation despite strong retail economics. It sees scope to expand India stores from about 2,500 to

Key facts

  • HSBC target price: Rs 513
  • Implied upside: about 2%
  • Organised eyewear market share: around 20%
  • Industry annual growth expectation: around 13%
  • Current stores in India: about 2,500
  • Potential India store network: around 7,000
  • Store payback: less than one year

Why this matters

The estimated headroom for up to 7,000 India stores reinforces the strategic value of securing high-quality retail sites, local partnerships and scalable market-entry capabilities.

What to watch

  • Quarterly net store additions versus management's stated rollout cadence.
  • Store payback period, new-store cohort revenue and mature-store same-store sales growth.
  • EBITDA margin trend after rent, staffing and marketing costs associated with expansion.
  • Online-to-store and store-to-online customer conversion, repeat purchase rates and fulfillment costs.
  • Evidence of cannibalization in dense urban clusters or weaker productivity in tier-2 and tier-3 markets.
  • Any valuation reset from earnings misses, lock-up/share-supply changes, or revised broker targets.
  • Prioritize cluster-based openings in tier-2 and tier-3 cities to preserve brand awareness and delivery density rather than pursuing isolated locations.
  • Use stores as omnichannel service hubs for eye tests, adjustments, returns and online order fulfillment, increasing sales per customer beyond walk-in transactions.
  • Expand lower-capex or franchise-like formats selectively if smaller-city demand is proven, while retaining control over clinical service and product assortment.
  • Maintain measured investor messaging: emphasize store-level ROI, mature-store sales growth and EBITDA conversion over headline store-count targets.
  • Competitors may respond with local promotions, faster delivery, private-label eyewear and optometrist partnerships, increasing acquisition and retention costs.